{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":5,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"5756479a69f8","filters":{"venue":"Journal of Drug Assessment"}},"results":[{"id":"W2604901999","doi":"10.1080/21556660.2017.1315336","title":"Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"Journal of Drug Assessment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"CD22; Medicine; Refractory (planetary science); Calicheamicin; Lymphoma; Internal medicine; Oncology; CD20","authors":[{"name":"Randeep Sangha","is_ca":false},{"name":"Andrew Davies","is_ca":false},{"name":"Nam H. Dang","is_ca":false},{"name":"Michinori Ogura","is_ca":false},{"name":"David MacDonald","is_ca":true},{"name":"Revathi Ananthakrishnan","is_ca":false},{"name":"M. Luisa Paccagnella","is_ca":false},{"name":"Erik Vandendries","is_ca":false},{"name":"Joseph Boni","is_ca":false},{"name":"Yeow Tee Goh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01537253524744568,"gpt":0.3181207012641905,"spread":0.3027481660167448,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001023971,0.001148154,0.00181583,0.0003097122,0.0003199836,0.0007075715,0.0007335089,0.0006866509,0.001629749],"category_scores_gemma":[0.0006153464,0.0004762282,0.0006963826,0.0002719772,0.0006741449,0.0005685523,0.0002874408,0.002058132,0.0004626241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007646114,"about_ca_system_score_gemma":0.001175639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007619043,"about_ca_topic_score_gemma":0.002290367,"domain_scores_codex":[0.9996781,0.0001637109,0.00001449072,0.0000564671,0.00003372917,0.00005338993],"domain_scores_gemma":[0.9996477,0.00005082905,0.00008469437,0.00003079141,0.00002373038,0.0001622406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4914964,0.1151799,0.01602267,0.001550826,0.002575628,0.00092591,0.0008292813,0.005477171,0.1693881,0.0003882249,0.004239894,0.1919261],"study_design_scores_gemma":[0.3567466,0.6057998,0.01949683,0.00004704341,0.0007163105,0.0005912547,0.00007493666,0.00172333,0.01133778,0.0001026901,0.003332459,0.00003101082],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965118,0.001162061,0.0003253003,0.0001597419,0.00004052767,0.0009300906,0.0002292404,0.00004513795,0.0005962704],"genre_scores_gemma":[0.9953916,0.001084941,0.000921005,0.0002871216,0.00007868038,0.0008251739,0.000646651,0.00001549657,0.0007493457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00181583,"threshold_uncertainty_score":0.005547643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2980673510","doi":"10.1080/21556660.2019.1678478","title":"The effectiveness and safety of pharmaceuticals to manage excess weight post-bariatric surgery: a systematic literature review","year":2019,"lang":"en","type":"article","venue":"Journal of Drug Assessment","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Maple Leaf Medical Clinic; York University","funders":"","keywords":"Medicine; Weight loss; Phentermine; Topiramate; Weight management; Placebo; Surgery; Randomized controlled trial; Obesity; Weight Loss Surgery; Gastric bypass surgery; Cochrane Library; Gastric bypass; Internal medicine; Alternative medicine","authors":[{"name":"Sean Wharton","is_ca":true},{"name":"Elham Kamran","is_ca":true},{"name":"Mahnoor Muqeem","is_ca":true},{"name":"Amina Khan","is_ca":true},{"name":"Rebecca Christensen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009661768118087525,"gpt":0.3224925958930861,"spread":0.3128308277749986,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006982974,0.001309772,0.007222168,0.01193312,0.0006957707,0.002470522,0.001660893,0.002193832,0.003417701],"category_scores_gemma":[0.03857757,0.001012358,0.007272455,0.009435893,0.0008982457,0.002178365,0.001337651,0.00109204,0.0002512802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002855294,"about_ca_system_score_gemma":0.01035509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005362065,"about_ca_topic_score_gemma":0.01861562,"domain_scores_codex":[0.9915717,0.002403004,0.00377971,0.0005500864,0.001494725,0.0002008186],"domain_scores_gemma":[0.9659187,0.02320753,0.007547697,0.0003798879,0.002615426,0.0003306661],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001786061,0.00001932183,0.0009828757,0.9664914,0.008910003,0.00009977665,0.0001327361,0.00004639916,0.0001163801,0.00009479024,0.0006986892,0.02222907],"study_design_scores_gemma":[0.0003027394,0.0003623634,0.005816355,0.8889673,0.09105159,0.000606948,0.0003415965,0.0000740929,0.0002126068,0.000196053,0.01203048,0.00003788133],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001522682,0.9973614,0.00008837513,0.0002112977,0.00007696022,0.0002345293,0.0002937749,0.000005436899,0.0002055195],"genre_scores_gemma":[0.01917104,0.9786488,0.0006486477,0.0006216989,0.0001030071,0.0004702953,0.0002402458,0.00000486998,0.00009133516],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01193312,"threshold_uncertainty_score":0.03692991,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049723660","doi":"10.3109/21556660.2013.792823","title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of belimumab in Japanese patients with mild-to-moderate systemic lupus erythematosus","year":2013,"lang":"en","type":"article","venue":"Journal of Drug Assessment","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"European Commission","keywords":"Belimumab; Medicine; Tolerability; Pharmacokinetics; Adverse effect; Placebo; Pharmacodynamics; Pharmacology; Dosing; Internal medicine; B-cell activating factor; Immunology; Antibody; B cell; Pathology","authors":[{"name":"M. Yamada","is_ca":false},{"name":"Mikio Akita","is_ca":false},{"name":"Tomofumi Nakagawa","is_ca":false},{"name":"Naoki Takahashi","is_ca":false},{"name":"Akira Endo","is_ca":false},{"name":"Pascal Yoshida","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01096061283435954,"gpt":0.3053165700250582,"spread":0.2943559571906986,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007978213,0.0002496011,0.0006037229,0.000117028,0.0002675364,0.0002361101,0.0001081656,0.0002114672,0.0005538308],"category_scores_gemma":[0.0007970242,0.0001544968,0.0003133618,0.0001674398,0.0002585368,0.000206877,0.0001656264,0.0003569535,0.00012647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002550091,"about_ca_system_score_gemma":0.0003537681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008982709,"about_ca_topic_score_gemma":0.002016486,"domain_scores_codex":[0.9996917,0.0001452461,0.00003732462,0.00003389143,0.00005782571,0.00003409398],"domain_scores_gemma":[0.9995919,0.00007402706,0.0001521297,0.00001992803,0.00004665036,0.0001154059],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.151133,0.006560513,0.4410426,0.002710267,0.002249479,0.00131456,0.002174076,0.001587123,0.1640389,0.0001896342,0.001907573,0.2250922],"study_design_scores_gemma":[0.01284458,0.1088031,0.8619674,0.0001113169,0.001573533,0.002434007,0.0004877289,0.001582613,0.005642815,0.0001458368,0.004344631,0.00006238549],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972078,0.002137948,0.0001718645,0.00009031722,0.000006465964,0.00003587217,0.00003543277,0.000008561544,0.000305726],"genre_scores_gemma":[0.9991664,0.0004154626,0.0001598587,0.0000924083,0.00001255242,0.00001978256,0.00003662361,0.000001096473,0.00009589059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008982709,"threshold_uncertainty_score":0.004219353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3116289745","doi":"10.1080/21556660.2020.1854561","title":"Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients","year":2020,"lang":"en","type":"article","venue":"Journal of Drug Assessment","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Atara Biotherapeutics","keywords":"Medicine; Adverse effect; Lymphoproliferative disease; Lymphoma; Rituximab; CHOP; Chemotherapy; Disease; Lymphoproliferative disorders; Internal medicine; Oncology; Intensive care medicine","authors":[{"name":"Crystal Watson","is_ca":false},{"name":"Arie Barlev","is_ca":false},{"name":"Jodie Worrall","is_ca":false},{"name":"Steve Duff","is_ca":false},{"name":"Rachel Beckerman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02422280134527305,"gpt":0.2976380105352367,"spread":0.2734152091899636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00915384,0.001056413,0.005051141,0.02041828,0.0006454379,0.00297691,0.001429725,0.001841556,0.003615572],"category_scores_gemma":[0.03803603,0.0007995028,0.006832087,0.0177113,0.0007211049,0.002211686,0.001529702,0.0009993984,0.0002529002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00311943,"about_ca_system_score_gemma":0.009874698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006149975,"about_ca_topic_score_gemma":0.01535801,"domain_scores_codex":[0.9920138,0.002129829,0.003905846,0.0005056884,0.001218854,0.0002261121],"domain_scores_gemma":[0.9544505,0.03361147,0.007313036,0.000495113,0.003766432,0.0003634771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00020903,0.00002512603,0.002364876,0.9333693,0.009312984,0.0002537477,0.0003573127,0.0001593781,0.0002182254,0.0003676215,0.001842958,0.05151956],"study_design_scores_gemma":[0.0001139573,0.0002556348,0.01070482,0.8893271,0.07114122,0.001082486,0.0006441535,0.0001350217,0.0002086144,0.0005328493,0.0258049,0.0000491966],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001951262,0.9964299,0.0001171006,0.0004281679,0.00007561008,0.000138657,0.0005181603,0.000004608099,0.000336626],"genre_scores_gemma":[0.02043177,0.9776804,0.0005241204,0.0005981271,0.0001024313,0.0002670853,0.0003186445,0.000004783484,0.00007266722],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02041828,"threshold_uncertainty_score":0.04841071,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2972150441","doi":"10.1080/21556660.2019.1658313","title":"Understanding purchasing patterns and product access of newly launched specialty generics","year":2019,"lang":"en","type":"article","venue":"Journal of Drug Assessment","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Product (mathematics); Purchasing; Pharmacy; Launched; Specialty; Marketing; Business; Medicine; Advertising; Family medicine; Engineering","authors":[{"name":"Stacey Ness","is_ca":false},{"name":"Ron Lucas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1615809875011352,"gpt":0.3508699535733115,"spread":0.1892889660721763,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001207564,0.0002244853,0.0002354369,0.001269969,0.000207564,0.0009923796,0.0003896503,0.0005540707,0.004541763],"category_scores_gemma":[0.005891973,0.000222992,0.0005829092,0.002611371,0.0001624403,0.001611917,0.0007116005,0.0008128932,0.001003315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000718975,"about_ca_system_score_gemma":0.0007201501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04256643,"about_ca_topic_score_gemma":0.06799283,"domain_scores_codex":[0.9996995,0.00007246263,0.00003707706,0.00005959614,0.00008252905,0.00004889805],"domain_scores_gemma":[0.9960954,0.001417893,0.00160299,0.0001208831,0.0003768445,0.0003859018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001683762,0.00008899164,0.9426602,0.00008078315,0.0001621066,0.00008190996,0.0003412463,0.0006933641,0.0001709551,0.000726794,0.008447844,0.04637747],"study_design_scores_gemma":[0.00001041876,0.00007484702,0.9900315,0.00007660561,0.00008539757,0.0001185559,0.0005530407,0.002615043,0.0001109967,0.00114737,0.005164938,0.0000113495],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.952678,0.006180619,0.0009062872,0.00734057,0.00004833262,0.00002147407,0.02827209,0.00002057155,0.004532102],"genre_scores_gemma":[0.9791756,0.003059165,0.001408928,0.0006714959,0.00008171686,0.00002296077,0.0139731,0.000007957857,0.001599148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04256643,"threshold_uncertainty_score":0.08463728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}